Intraocular Pressure

Sub-Tenon injection of mitomycin C may be an alternative to conventional application of MMC with sponges, according to a study.

SAN FRANCISCO — In this video from Glaucoma 360 New Horizons Forum, Thurein Htoo, MS, MBA, CEO of Qlaris Bio, discusses the importance of lowering episcleral venous pressure, or EVP.

NASHVILLE, Tenn. — Patients with open-angle glaucoma had favorable outcome 3 years after undergoing stand-alone SIBS microshunt implantation, according to a study.

SAN FRANCISCO — In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Barbara Wirostko, MD, FARVO, discusses the expanding horizon of new glaucoma devices.

AUSTIN, Texas — In this Healio Video Perspective from the North American Neuro-Ophthalmology Society meeting, Randy H. Kardon, MD, discusses the potential impact of a multi-pressure dial (Equinox) on blood flow and various eye diseases.

SAN FRANCISCO — In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Ronald L. Fellman, MD, discusses the importance of being adept when managing the stages of glaucoma.

The iDose TR demonstrated sustained IOP reduction at 36 months, according to a press release from Glaukos.

December glaucoma news includes updates on standalone MIGS surgery as well as a video from the American Academy of Ophthalmology meeting.

The first patient has been enrolled in a trial investigating the stand-alone use of the Hydrus microstent in mild to moderate open-angle glaucoma, according to a press release from Ivantis.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Brian Flowers, MD, discusses results of the Glaukos iStent infinite trial in patients with advanced glaucoma.